CLOSE X
GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
29.90 0.32(1.08%) NAV as on 05 Feb 2025
-6.82 % 1 M
16.52 % 1 Y
17.4 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.27

As on 31 Dec, 2024
age-icon Age :

5 yrs 6 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

890.33 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.74

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on Dec 31 ,2024
Others 3.49 %
Equity 96.51 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.54 %
Cipla Ltd.8.62 %
Torrent Pharmaceuticals Ltd.8.10 %
Apollo Hospitals Enterprise Ltd.6.06 %
Lupin Ltd.5.19 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs77.84
Hospital & Healthcare Services16.19
Business Support1.69
Chemicals0.79
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 04-Feb-2025)16.1218.2216.3626.4529.58
Net Assets(Rs Crores) (as on 04-Feb-2025) 454.91 515.33 428.44 699.55 890.33
Scheme Returns(%)(Absolute)63.4912.40-10.2661.3810.75
B'mark Returns(%)(Absolute)NANANANANA
Category Rank55/7549/7570/7611/9039/98

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity29.900.32(1.08%)NAV As on 05 Feb, 202510-Jul-2019Inception Date890.33AUM In Cr.16.52%1Y17.40%3Y21.61%5Y21.68%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity422.096.90(1.66%)NAV As on 05 Feb, 202514-Jul-1999Inception Date3,628.03AUM In Cr.29.31%1Y23.55%3Y27.76%5Y16.50%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.700.25(0.67%)NAV As on 05 Feb, 202513-Jul-2018Inception Date5,320.29AUM In Cr.29.73%1Y23.52%3Y28.42%5Y22.37%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.020.30(1.02%)NAV As on 05 Feb, 202528-Dec-2015Inception Date1,287.45AUM In Cr.24.45%1Y20.41%3Y25.45%5Y12.82%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors